ARCHIVES

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

New CCP Lineup remains Unclear; 11 Bases OK’d

April 5, 1991

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

NCI-Approved Clinical Trials Listed For May 2001

June 29, 2001